Interview: Daniel de Labauve d’Arifat – CEO, PNL (Pharmacie Nouvelle Limited), Mauritius
12.01.2016
Related Interviews
Interview: Bertrand Baudot – Managing Director, QuantiLAB, Mauritius
After recently signing a service level agreement with Mérieux NutriSciences in May 2015, Bertrand Baudot, Managing Director of QuantiLAB explains the company’s plans for the future. He also discusses the…
Interview: Paul Corson – Head of Corporate Banking, Mauritius Commercial…
The Head of Corporate & Institutional Banking of the Mauritius Commercial Bank explains why the diversification of the Mauritian economy into the healthcare and life sciences sector is necessary and…
Interview: Joel Bruneau – Head of Property Development, Omnicane,…
”The Mon Trésor Smart City will cater to the business needs of the global healthcare and life sciences sector as no other smart city can.” The Head of Property Development…
Australia / Artificial Intelligence Can Save Pharmacovigilance
Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…
China / Emerging Pharmacovigilance Framework Ensuring Safe COVID-19 Vaccines
PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective pharmacovigilance ecosystem is helping to safeguard the rollout of…
Spain / 5 Key Industry Trends 2021
According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends…
Latest Report
